US20040122339A1 - Sampling devices and methods utilizing biased capillary action - Google Patents
Sampling devices and methods utilizing biased capillary action Download PDFInfo
- Publication number
- US20040122339A1 US20040122339A1 US10/732,615 US73261503A US2004122339A1 US 20040122339 A1 US20040122339 A1 US 20040122339A1 US 73261503 A US73261503 A US 73261503A US 2004122339 A1 US2004122339 A1 US 2004122339A1
- Authority
- US
- United States
- Prior art keywords
- fluid
- capillary channel
- bias
- test strip
- capillary
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150358—Strips for collecting blood, e.g. absorbent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150015—Source of blood
- A61B5/150022—Source of blood for capillary blood or interstitial fluid
Definitions
- the present invention generally relates to the medical field, and more specifically, but not exclusively, relates to the sampling of bodily fluids.
- the acquisition and testing of body fluids is useful for many purposes, and continues to be of importance for use in medical diagnosis and treatment, and in other diverse applications.
- Testing can be performed on various body fluids, and for certain applications, it is particularly related to testing of blood and/or interstitial fluid.
- Such fluids can be tested for a variety of characteristics of the fluid or analytes contained in the fluid, in order to identify medical conditions, determine therapeutic responses, assess progress of treatments and the like.
- a common medical test is the measurement of blood glucose levels.
- the glucose level can be determined directly by analysis of the blood, or indirectly by analysis of other fluids, such as interstitial fluid.
- Diabetics are generally instructed to measure their glucose levels several times a day, depending on the nature and severity of their diabetes. Based upon observed patterns in the measurement of glucose levels, the patient and physician can determine the appropriate level of insulin to be administered, also taking into account such issues as diet, exercise and other factors.
- test systems In testing for the presence of analytes such as glucose in a body fluid, test systems are commonly used which take advantage of oxidation/reduction reaction, which occurs using an oxidase/peroxidase detection chemistry.
- the testing reagent is exposed to a sample of the body fluid for a suitable period of time, and there is a color change if analyte (glucose) is present.
- analyte glucose
- the intensity of the change is proportional to the concentration of analyte in the sample.
- the color of the reagent is then compared to a known standard, which enables one to determine the amount of analyte present in the sample.
- This determination can be made, for example, by visual check or by an instrument, such as a spectrophotometer at a selected wave length, or a blood glucose meter.
- Electrochemical and other systems are also well known for testing body fluids for properties of constituents. Typically, a fingertip or some other body location of a patient is lanced with a lancet in order to obtain a body fluid sample.
- fingertips generally provide an ample supply of blood, repeated lancing of fingertips can be quite painful due to the high concentration of nerve endings in the fingertips. Therefore, there has been a trend towards sampling fluids from alternate sites on the body, where the nerve concentrations are lower, such as the forearm. As should be appreciated, since alternate sites have lower nerve concentrations, the patient experiences less pain when lancing the alternate site. However, these alternate sites usually produce less fluid as compared to fingertips. Consequently, it has been a goal to reduce the amount of fluid needed for a successful test. To achieve this goal, it is desirable to ensure that as much fluid as possible is transported from the incision to the test area so as to minimize waste.
- FIG. 1 is an isometric view of a portion of an example apparatus according to the present invention.
- FIG. 2A is an end view of the apparatus of FIG. 1.
- FIG. 2B is a side view of the apparatus of FIG. 1.
- FIG. 2C is a cross-sectional view taken along line 2 C- 2 C of FIG. 2B.
- FIG. 3 is a side view of the apparatus of FIG. 1 disposed above body fluid on a tissue surface.
- FIG. 4 is a side view illustrating the apparatus of FIG. 1 displaying the initial capillary action.
- FIG. 5 is a side view illustrating the apparatus of FIG. 1 displaying biased capillary action.
- FIG. 6 is a side view of a portion of an alternative example apparatus according:to the present invention displaying another form of biased capillary action.
- FIG. 7 is a side view of the apparatus of FIG. 6 illustrating a test strip disposed within a groove in the apparatus.
- FIG. 8 is a side view of a portion of another alternative example apparatus according to the present invention.
- FIG. 9 is a side view of the apparatus of FIG. 8 displaying another form of biased capillary action.
- FIG. 10 is a side view of the apparatus of FIG. 8 illustrating a test strip disposed within a groove in the apparatus.
- FIG. 11 is a side view of a portion of yet another alternative example apparatus according to the present invention.
- FIG. 12 is an isometric view of a portion of another example apparatus according to the present invention.
- the present invention generally concerns a sampling device that is configured to bias the flow of body fluid in the device so as to reduce the amount of fluid needed for sampling.
- the device has a capillary channel that is structured to bias a miniscus of the fluid in a radially asymmetric manner.
- the capillary channel has an angled counter bore that biases the meniscus of the fluid in a radial asymmetric manner.
- the capillary channel includes hydrophobic and hydrophillic portions that bias the flow of fluid.
- FIG. 1 illustrates one example of a device 100 for sampling body fluid (not shown), comprising a main body 110 defining a capillary channel 120 .
- the capillary channel 120 is preferably dimensioned to draw a body fluid into the capillary channel 120 through capillary action, as described more fully in the above-incorporated patent applications.
- the capillary channel 120 is further dimensioned to form an angled counterbore 130 .
- the device 100 is shown in FIG. 1 as cylindrical with an annular cross-section, this is just one example geometry. Any geometry can be used for device 100 , as long as device 100 provides a capillary channel 120 dimensioned to draw a body fluid into said capillary channel 120 through capillary action.
- device 100 may comprise any material and may be made by any means, such as the materials and methods of manufacture set forth in the above-incorporated patent applications.
- FIGS. 2A, 2B and 2 C further illustrates the example of FIG. 1.
- the device, or apparatus, 100 comprises a body 110 defining a capillary channel 120 having a first region 140 and a second region 150 and a proximal portion 160 and a distal portion 170 .
- the second region 150 of the capillary channel 120 defines a counterbore 130 ending in a surface non-normal to the longitudinal axis 180 of the capillary channel 120 by angle ⁇ .
- FIG. 3 illustrates the device 100 positioned above a drop of body fluid 310 issuing from an incision 305 in body tissue 300 .
- the body fluid 310 may be produced by puncturing the body tissue 300 , or by any other means, including as described in the above-incorporated patent applications.
- FIG. 4 illustrates the device 100 lowered toward the body tissue 300 until the proximal portion 160 of the capillary channel 120 is in fluid communication with the body fluid 310 .
- the body fluid 310 is then drawn into the capillary channel 120 by capillary action, as represented in FIGS. 4 and 5.
- the body fluid 310 flows in the capillary channel 120 from the proximal portion 160 toward the distal portion 170 .
- the meniscus 320 of the body fluid 310 is biased radially asymmetrically about the centerline 180 toward one side of capillary channel 120 , as shown in FIG. 5.
- Capillary mechanics dictate that the step or offset created by the angled counterbore 130 causes the first region 140 to have an effectively stronger capillary attraction to body fluid 310 than the second region 150 when the body fluid 310 flows in the capillary channel 120 from the proximal portion 160 toward the distal portion 170 .
- an angled counterbore 130 is shown as an example, any geometry including a step or other shape can be used that has the capillary biasing effect of biasing the forces of capillary action acting on body fluid 310 so that they are radially asymmetric about the centerline 180 , such as by tending to favor one side of capillary channel 120 .
- This difference in capillary attraction pulls or biases the meniscus 320 radially asymmetrically about the centerline 180 , toward the first region 140 and away from the second region 150 , thus biasing the body fluid 310 toward a first side 122 of the capillary channel 120 , and away from a second side 124 of the capillary channel 120 .
- increasing the angle ⁇ tends to increasingly bias the body fluid 310 toward a first side 122 of the capillary channel 120 , and away from a second side 124 of the capillary channel 120 .
- FIG. 6 shows a device 100 ′ that is similar to device 100 , but has a counterbore 130 ′ with an increased angle ⁇ ′.
- increasing the angle from ⁇ to ⁇ ′ tends to increase the bias of the meniscus 320 radially asymmetrically about the centerline 180 , thus tending to increase the bias of the body fluid 310 toward a first side 122 of the capillary channel 120 , and away from a second side 124 of the capillary channel 120 .
- FIG. 7 shows the device 100 ′ of FIG. 6 further including a testing element 700 disposed within a groove 710 in the main body 110 ′ of the device 100 ′′.
- the testing element 700 is in spatial communication with body fluid 310 through one or more passageways 720 , so that the testing element 700 may be used to test various aspects of the body fluid 310 , for instance as described in the above-incorporated patent applications.
- Testing element 700 may be any testing means that interfaces with body fluid 310 , such as a test strip or other chemistry, for instance as described in the above-incorporated patent applications.
- passageways 720 are shown formed in the first side 122 of the capillary channel 120 . Passageways 720 are filled with body fluid 310 , even though the adjacent portion of the capillary channel 120 is only partially filled with body fluid 310 due to the biasing effect described above.
- the device 100 ′′ is capable of communicating body fluid 310 to testing element 700 using less body fluid 310 than would be required without the capillary biasing effect described herein.
- FIG. 8 illustrates another example device 100 ′′ configured to create a capillary biasing effect without requiring an angled counterbore 130 or any geometry such as a step or other shape in the capillary channel 120 .
- the first side 122 of the capillary channel 120 includes a hydrophilic region 800 .
- the hydrophilic region 800 is hydrophilic relative to one or more adjacent regions of the capillary channel 120 , such as the second side 124 .
- the hydrophilic region 800 need only be relatively hydrophilic; for instance, the hydrophilic region 800 may be defined by providing hydrophobic surrounding regions.
- a relatively hydrophilic region 800 may be created by forming portions of the capillary channel 120 from hydrophilic or hydrophobic materials, or by treating portions to be relatively hydrophilic or hydrophobic, for instance in the manners described in the above-incorporated patent applications.
- FIG. 9 illustrates the device 100 ′′ of FIG. 8 positioned near body tissue 300 so that the proximal portion 160 of the capillary channel 120 is in fluid communication with a small drop of body fluid 310 issuing from an incision 305 in body tissue 300 , the body fluid 310 being drawn into the capillary channel 120 by capillary action.
- the body fluid 310 reaches the relatively hydrophilic region 800 , the body fluid 310 is disproportionately attracted to the hydrophilic region 800 .
- This difference in capillary attraction pulls or biases the meniscus 320 radially asymmetrically about the centerline 180 , thus biasing the body fluid 310 toward the relatively hydrophilic region 800 of the first side 122 of the capillary channel 120 , and away from the relatively hydrophobic second side 124 of the capillary channel 120 .
- FIG. 10 shows the device 100 ′′ of FIG. 9 further including a testing element 700 disposed within a groove 710 in the main body 110 ′′ of the device 100 ′′.
- the testing element 700 is in spatial communication with body fluid 310 through one or more passageways 720 , so that the testing element 700 may be used to test various aspects of the body fluid 310 , as set forth above. Since the body fluid 310 tends to bias toward the hydrophilic region 800 on the first side 122 of the capillary channel 120 , passageways 720 are shown formed in the first side 122 of the capillary channel 120 .
- Passageways 720 are filled with body fluid 310 , even though the adjacent portion of the capillary channel 120 is only partially filled with body fluid 310 due to the biasing effect described above.
- the device 100 ′′ is capable of communicating body fluid 310 to testing element 700 using less body fluid 310 than would be required without the capillary biasing effect described herein.
- FIG. 11 shows a device 100 ′′′ including by way of example both an angled counterbore 130 and a relatively hydrophilic region 800 in the capillary channel 120 , and further including an integrated lancet 1100 for forming the incision 305 .
- the integrated lancet 1100 may be used in conjunction with devices incorporating the capillary biasing effect described herein.
- devices including an integrated lancet 1100 can include any or all of the structure set forth in the above-incorporated patent applications.
- an angled counterbore 130 works in conjunction with a relatively hydrophilic region 800 to bias body fluid 310 toward testing element 700 using less body fluid 310 than would be required without the capillary biasing effect described herein.
- FIG. 12 illustrates a capillary tube 1200 according to another embodiment of the present invention.
- the capillary tube 1200 has a stepped-end counterbore 1202 for biasing the fluid in a specified direction inside the capillary tube.
- a plurality of sites on a testing device might be used for testing the same or different characteristics of the body fluid. Those sites might be spaced around the circumference of the device at approximately the same distance from the proximal end, or they might be situated at different distances from the proximal end. They may be on the same side of the device, opposite sides of the device, or in some other relative configuration.
- test methods may be implemented at the one or more test sites, including for example optical, magnetic, and chemical tests as would occur to one skilled in the art given the disclosure herein, which includes the matter incorporated by reference above.
- a wide variety of techniques might be used to bias the body fluid toward the testing site(s). These techniques might include (but are not limited to) the angled-end counterbore and hydrophobic/hydrophilic wall techniques discussed above; chemically treating or coating one or more portions of the inner wall of the capillary tube with one or more different hydrophobic, hydrophilic, or other chemicals known in the art; the stepped-end counterbore 1202 as shown in FIG. 12; roughening the inner wall of the capillary tube in one region relative to another; and forming longitudinal grooves in certain portions of the inner wall (or more grooves in certain portions than in others).
Abstract
A device is constructed so as to define a capillary channel that draws a body fluid form a proximal portion of the capillary channel toward a distal portion. A counterbore defining a “ledge” not substantially normal to the center line of channel causes the meniscus of body fluid to be “biased” into a non-radially-symmetric shape. In one example, the bias draws the body fluid toward a testing element that is set into a groove in the main body of the device. In another example, hydrophilic and/or hydrophobic regions are created on or in device to produce the biasing effect. In certain configurations, device requires less blood to be drawn into the capillary channel for a successful test than if the biasing effect were not created.
Description
- This application claims the benefit of U.S. Provisional Application No. 60/436,331, filed Dec. 24, 2002 (Attorney Docket No. 7404-453), which is hereby incorporated by reference in its entirety.
- The present invention generally relates to the medical field, and more specifically, but not exclusively, relates to the sampling of bodily fluids.
- The acquisition and testing of body fluids is useful for many purposes, and continues to be of importance for use in medical diagnosis and treatment, and in other diverse applications. In the medical field, it is desirable for lay operators to perform tests routinely, quickly and accurately outside of a laboratory setting, with rapid results and a read-out of the resulting test information. Testing can be performed on various body fluids, and for certain applications, it is particularly related to testing of blood and/or interstitial fluid. Such fluids can be tested for a variety of characteristics of the fluid or analytes contained in the fluid, in order to identify medical conditions, determine therapeutic responses, assess progress of treatments and the like.
- A common medical test is the measurement of blood glucose levels. The glucose level can be determined directly by analysis of the blood, or indirectly by analysis of other fluids, such as interstitial fluid. Diabetics are generally instructed to measure their glucose levels several times a day, depending on the nature and severity of their diabetes. Based upon observed patterns in the measurement of glucose levels, the patient and physician can determine the appropriate level of insulin to be administered, also taking into account such issues as diet, exercise and other factors.
- In testing for the presence of analytes such as glucose in a body fluid, test systems are commonly used which take advantage of oxidation/reduction reaction, which occurs using an oxidase/peroxidase detection chemistry. The testing reagent is exposed to a sample of the body fluid for a suitable period of time, and there is a color change if analyte (glucose) is present. Typically, the intensity of the change is proportional to the concentration of analyte in the sample. The color of the reagent is then compared to a known standard, which enables one to determine the amount of analyte present in the sample. This determination can be made, for example, by visual check or by an instrument, such as a spectrophotometer at a selected wave length, or a blood glucose meter. Electrochemical and other systems are also well known for testing body fluids for properties of constituents. Typically, a fingertip or some other body location of a patient is lanced with a lancet in order to obtain a body fluid sample.
- Although fingertips generally provide an ample supply of blood, repeated lancing of fingertips can be quite painful due to the high concentration of nerve endings in the fingertips. Therefore, there has been a trend towards sampling fluids from alternate sites on the body, where the nerve concentrations are lower, such as the forearm. As should be appreciated, since alternate sites have lower nerve concentrations, the patient experiences less pain when lancing the alternate site. However, these alternate sites usually produce less fluid as compared to fingertips. Consequently, it has been a goal to reduce the amount of fluid needed for a successful test. To achieve this goal, it is desirable to ensure that as much fluid as possible is transported from the incision to the test area so as to minimize waste.
- Thus, there remains a need for improvement in this field.
- FIG. 1 is an isometric view of a portion of an example apparatus according to the present invention.
- FIG. 2A is an end view of the apparatus of FIG. 1.
- FIG. 2B is a side view of the apparatus of FIG. 1.
- FIG. 2C is a cross-sectional view taken along
line 2C-2C of FIG. 2B. - FIG. 3 is a side view of the apparatus of FIG. 1 disposed above body fluid on a tissue surface.
- FIG. 4 is a side view illustrating the apparatus of FIG. 1 displaying the initial capillary action.
- FIG. 5 is a side view illustrating the apparatus of FIG. 1 displaying biased capillary action.
- FIG. 6 is a side view of a portion of an alternative example apparatus according:to the present invention displaying another form of biased capillary action.
- FIG. 7 is a side view of the apparatus of FIG. 6 illustrating a test strip disposed within a groove in the apparatus.
- FIG. 8 is a side view of a portion of another alternative example apparatus according to the present invention.
- FIG. 9 is a side view of the apparatus of FIG. 8 displaying another form of biased capillary action.
- FIG. 10 is a side view of the apparatus of FIG. 8 illustrating a test strip disposed within a groove in the apparatus.
- FIG. 11 is a side view of a portion of yet another alternative example apparatus according to the present invention.
- FIG. 12 is an isometric view of a portion of another example apparatus according to the present invention.
- Provided below is a written description of examples embodying the invention and examples of making and using the same. The scope of the invention is not limited to these examples, but rather is defined solely by the numbered claims that appear at the end of this document, and the invention includes alterations, modifications, and further applications that fall within the claims. The written description uses full, clear, concise, and exact terms to enable any person skilled in the art to which the invention pertains to make and use the invention. The best mode contemplated by the inventor of carrying out the invention is also set forth herein.
- All the information set forth in the following patent applications is incorporated by reference, as if fully set forth herein: U.S. patent application Ser. No. 10/054,270, filed Jan. 22, 2002, entitled LANCET DEVICE HAVING CAPILLARY ACTION; and U.S. patent application Ser. No. 10/165,101, filed Jun. 7, 2002, entitled SAMPLING DEVICES AND METHODS UTILIZING A HORIZONTAL CAPILLARY TEST STRIP.
- The present invention generally concerns a sampling device that is configured to bias the flow of body fluid in the device so as to reduce the amount of fluid needed for sampling. In one embodiment, the device has a capillary channel that is structured to bias a miniscus of the fluid in a radially asymmetric manner. Specifically, the capillary channel has an angled counter bore that biases the meniscus of the fluid in a radial asymmetric manner. In another embodiment, the capillary channel includes hydrophobic and hydrophillic portions that bias the flow of fluid.
- FIG. 1 illustrates one example of a
device 100 for sampling body fluid (not shown), comprising amain body 110 defining acapillary channel 120. Thecapillary channel 120 is preferably dimensioned to draw a body fluid into thecapillary channel 120 through capillary action, as described more fully in the above-incorporated patent applications. In this example thecapillary channel 120 is further dimensioned to form anangled counterbore 130. - Though the
device 100 is shown in FIG. 1 as cylindrical with an annular cross-section, this is just one example geometry. Any geometry can be used fordevice 100, as long asdevice 100 provides acapillary channel 120 dimensioned to draw a body fluid into saidcapillary channel 120 through capillary action. For example, one or more portions ofdevice 100 and/orcapillary channel 120 could independently have square, rectangular, triangular, oval, U-shaped, amorphous, or any other shape cross-sections.Device 100 may comprise any material and may be made by any means, such as the materials and methods of manufacture set forth in the above-incorporated patent applications. - FIGS. 2A, 2B and2C further illustrates the example of FIG. 1. The device, or apparatus, 100 comprises a
body 110 defining acapillary channel 120 having afirst region 140 and asecond region 150 and aproximal portion 160 and adistal portion 170. In the example shown in FIGS. 1-5, thesecond region 150 of thecapillary channel 120 defines acounterbore 130 ending in a surface non-normal to thelongitudinal axis 180 of thecapillary channel 120 by angle α. - FIG. 3 illustrates the
device 100 positioned above a drop ofbody fluid 310 issuing from anincision 305 inbody tissue 300. Thebody fluid 310 may be produced by puncturing thebody tissue 300, or by any other means, including as described in the above-incorporated patent applications. FIG. 4 illustrates thedevice 100 lowered toward thebody tissue 300 until theproximal portion 160 of thecapillary channel 120 is in fluid communication with thebody fluid 310. Thebody fluid 310 is then drawn into thecapillary channel 120 by capillary action, as represented in FIGS. 4 and 5. As shown in FIGS. 4 and 5, thebody fluid 310 flows in thecapillary channel 120 from theproximal portion 160 toward thedistal portion 170. However, when thebody fluid 310 reaches theangled counterbore 130, themeniscus 320 of thebody fluid 310 is biased radially asymmetrically about thecenterline 180 toward one side ofcapillary channel 120, as shown in FIG. 5. - Capillary mechanics dictate that the step or offset created by the
angled counterbore 130 causes thefirst region 140 to have an effectively stronger capillary attraction tobody fluid 310 than thesecond region 150 when thebody fluid 310 flows in thecapillary channel 120 from theproximal portion 160 toward thedistal portion 170. Though anangled counterbore 130 is shown as an example, any geometry including a step or other shape can be used that has the capillary biasing effect of biasing the forces of capillary action acting onbody fluid 310 so that they are radially asymmetric about thecenterline 180, such as by tending to favor one side ofcapillary channel 120. - This difference in capillary attraction pulls or biases the
meniscus 320 radially asymmetrically about thecenterline 180, toward thefirst region 140 and away from thesecond region 150, thus biasing thebody fluid 310 toward afirst side 122 of thecapillary channel 120, and away from asecond side 124 of thecapillary channel 120. Subject to the materials and dimensions used indevice 100 and their interaction with aparticular body fluid 310, increasing the angle α tends to increasingly bias thebody fluid 310 toward afirst side 122 of thecapillary channel 120, and away from asecond side 124 of thecapillary channel 120. - FIG. 6 shows a
device 100′ that is similar todevice 100, but has acounterbore 130′ with an increased angle α′. As shown in FIG. 6, increasing the angle from α to α′ tends to increase the bias of themeniscus 320 radially asymmetrically about thecenterline 180, thus tending to increase the bias of thebody fluid 310 toward afirst side 122 of thecapillary channel 120, and away from asecond side 124 of thecapillary channel 120. - FIG. 7 shows the
device 100′ of FIG. 6 further including atesting element 700 disposed within agroove 710 in themain body 110′ of thedevice 100″. Whenbody fluid 310 has moved upfirst side 122, as shown, thetesting element 700 is in spatial communication withbody fluid 310 through one ormore passageways 720, so that thetesting element 700 may be used to test various aspects of thebody fluid 310, for instance as described in the above-incorporated patent applications.Testing element 700 may be any testing means that interfaces withbody fluid 310, such as a test strip or other chemistry, for instance as described in the above-incorporated patent applications. - Since the
body fluid 310 tends to bias toward thefirst side 122 of thecapillary channel 120,passageways 720 are shown formed in thefirst side 122 of thecapillary channel 120.Passageways 720 are filled withbody fluid 310, even though the adjacent portion of thecapillary channel 120 is only partially filled withbody fluid 310 due to the biasing effect described above. Thus, thedevice 100″ is capable of communicatingbody fluid 310 totesting element 700 usingless body fluid 310 than would be required without the capillary biasing effect described herein. - FIG. 8 illustrates another
example device 100″ configured to create a capillary biasing effect without requiring anangled counterbore 130 or any geometry such as a step or other shape in thecapillary channel 120. Instead, thefirst side 122 of thecapillary channel 120 includes ahydrophilic region 800. Thehydrophilic region 800 is hydrophilic relative to one or more adjacent regions of thecapillary channel 120, such as thesecond side 124. Thehydrophilic region 800 need only be relatively hydrophilic; for instance, thehydrophilic region 800 may be defined by providing hydrophobic surrounding regions. A relativelyhydrophilic region 800 may be created by forming portions of thecapillary channel 120 from hydrophilic or hydrophobic materials, or by treating portions to be relatively hydrophilic or hydrophobic, for instance in the manners described in the above-incorporated patent applications. - FIG. 9 illustrates the
device 100″ of FIG. 8 positioned nearbody tissue 300 so that theproximal portion 160 of thecapillary channel 120 is in fluid communication with a small drop ofbody fluid 310 issuing from anincision 305 inbody tissue 300, thebody fluid 310 being drawn into thecapillary channel 120 by capillary action. When thebody fluid 310 reaches the relativelyhydrophilic region 800, thebody fluid 310 is disproportionately attracted to thehydrophilic region 800. This difference in capillary attraction pulls or biases themeniscus 320 radially asymmetrically about thecenterline 180, thus biasing thebody fluid 310 toward the relativelyhydrophilic region 800 of thefirst side 122 of thecapillary channel 120, and away from the relatively hydrophobicsecond side 124 of thecapillary channel 120. - FIG. 10 shows the
device 100″ of FIG. 9 further including atesting element 700 disposed within agroove 710 in themain body 110″ of thedevice 100″. Thetesting element 700 is in spatial communication withbody fluid 310 through one ormore passageways 720, so that thetesting element 700 may be used to test various aspects of thebody fluid 310, as set forth above. Since thebody fluid 310 tends to bias toward thehydrophilic region 800 on thefirst side 122 of thecapillary channel 120,passageways 720 are shown formed in thefirst side 122 of thecapillary channel 120.Passageways 720 are filled withbody fluid 310, even though the adjacent portion of thecapillary channel 120 is only partially filled withbody fluid 310 due to the biasing effect described above. Thus, thedevice 100″ is capable of communicatingbody fluid 310 totesting element 700 usingless body fluid 310 than would be required without the capillary biasing effect described herein. - FIG. 11 shows a
device 100′″ including by way of example both anangled counterbore 130 and a relativelyhydrophilic region 800 in thecapillary channel 120, and further including anintegrated lancet 1100 for forming theincision 305. Theintegrated lancet 1100, or any other structure, may be used in conjunction with devices incorporating the capillary biasing effect described herein. For instance, devices including anintegrated lancet 1100 can include any or all of the structure set forth in the above-incorporated patent applications. In this example, anangled counterbore 130 works in conjunction with a relativelyhydrophilic region 800 to biasbody fluid 310 towardtesting element 700 usingless body fluid 310 than would be required without the capillary biasing effect described herein. - FIG. 12 illustrates a
capillary tube 1200 according to another embodiment of the present invention. In the illustrated embodiment, thecapillary tube 1200 has a stepped-end counterbore 1202 for biasing the fluid in a specified direction inside the capillary tube. - Various alternatives to the structures and details described herein are available, and could be implemented without undue experimentation by those skilled in the art. For example, a plurality of sites on a testing device might be used for testing the same or different characteristics of the body fluid. Those sites might be spaced around the circumference of the device at approximately the same distance from the proximal end, or they might be situated at different distances from the proximal end. They may be on the same side of the device, opposite sides of the device, or in some other relative configuration.
- Further, various test methods may be implemented at the one or more test sites, including for example optical, magnetic, and chemical tests as would occur to one skilled in the art given the disclosure herein, which includes the matter incorporated by reference above.
- Furthermore, a wide variety of techniques might be used to bias the body fluid toward the testing site(s). These techniques might include (but are not limited to) the angled-end counterbore and hydrophobic/hydrophilic wall techniques discussed above; chemically treating or coating one or more portions of the inner wall of the capillary tube with one or more different hydrophobic, hydrophilic, or other chemicals known in the art; the stepped-
end counterbore 1202 as shown in FIG. 12; roughening the inner wall of the capillary tube in one region relative to another; and forming longitudinal grooves in certain portions of the inner wall (or more grooves in certain portions than in others). - While examples embodying the invention have been illustrated and described in detail in the drawings and foregoing description, which includes material incorporated by reference, these examples are illustrative and not restrictive in character, it being understood that only certain examples have been shown and described and that all changes and modifications that come within the spirit of the invention are to be protected.
Claims (41)
1. A device comprising a main body that defines a capillary channel, wherein:
said capillary channel is dimensioned to draw a body fluid into said capillary channel by capillary action;
said body fluid defines a meniscus when said body fluid is drawn into said capillary channel; and
said capillary channel is constructed to tend to bias said meniscus in a radially asymmetric manner when said body fluid is drawn into said capillary channel.
2. The device of claim 1 wherein said bias tends to bias said fluid toward a testing element in spatial communication with said fluid.
3. The device of claim 2 wherein said testing element comprises a test strip.
4. The device of claim 3 wherein said test strip comprises a membrane.
5. The device of claim 3 wherein said test strip is mounted in a groove defined in said device.
6. A device for sampling body fluid, comprising a main body that defines a capillary channel, wherein:
said capillary channel is dimensioned to draw a body fluid into said capillary channel by capillary action;
said body fluid defines a meniscus when said body fluid is drawn into said capillary channel; and
said capillary channel has a relatively hydrophilic portion tending to bias said meniscus in a radially asymmetric manner when said body fluid is drawn into said capillary channel.
7. The device of claim 6 wherein said bias tends to bias said fluid toward a testing element in spatial communication with said fluid.
8. The device of claim 7 wherein said testing element comprises a test strip.
9. The device of claim 8 wherein said test strip comprises a membrane.
10. The device of claim 8 wherein said test strip is mounted in a groove defined in said device.
11. A fluid sampling device comprising a capillary tube defining a capillary channel adapted to contain fluid defining a meniscus, the capillary channel further adapted to impart a radially asymmetric bias to the meniscus of the fluid when the fluid is within the capillary channel.
12. The device of claim 11 , the capillary channel having an angled counterbore adapted to impart the radially asymmetric bias to the meniscus of the fluid when the fluid is within the capillary channel.
13. The device of claim 12 , wherein said bias tends to bias said fluid toward a testing element in spatial communication with said fluid.
14. The device of claim 13 , wherein said testing element comprises a test strip.
15. The device of claim 14 , wherein said test strip comprises a membrane.
16. The device of claim 14 , wherein said test strip is mounted in a groove defined in said device.
17. The device of claim 11 , the capillary channel having a hydrophilic region adapted to impart the radially asymmetric bias to the meniscus of the fluid when the fluid is within the capillary channel.
18. The device of claim 17 , wherein said bias tends to bias said fluid toward a testing element in spatial communication with said fluid.
19. The device of claim 18 , wherein said testing element comprises a test strip.
20. The device of claim 19 , wherein said test strip comprises a membrane.
21. The device of claim 19 , wherein said test strip is mounted in a groove defined in said device.
22. A device, comprising:
a body defining a capillary channel having a first region and a second region and a proximal portion and a distal portion;
the first region having a first capillary attraction to a fluid when the fluid flows in the capillary channel from the proximate portion toward the distal portion;
the second region having a second capillary attraction to the fluid when the fluid flows in the capillary channel from the proximate portion toward the distal portion; and
the first capillary attraction being stronger than the second capillary attraction sufficiently to bias the flow of the fluid within the capillary channel toward the first region when the fluid flows in the capillary channel from the proximate portion toward the distal portion.
23. The device of claim 22 wherein said bias tends to bias said fluid toward a testing element in spatial communication with said fluid.
24. The device of claim 23 , wherein said testing element comprises a test strip.
25. The device of claim 24 , wherein said test strip comprises a membrane.
26. The device of claim 24 , wherein said test strip is mounted in a groove defined in said device.
27. A fluid sampling device comprising body means defining capillary channel means, wherein the capillary channel means includes means for biasing the meniscus of fluid within the capillary channel means.
28. The device of claim 27 , wherein said bias tends to bias said fluid toward a testing element in spatial communication with said fluid.
29. The device of claim 28 , wherein said testing element comprises a test strip.
30. The device of claim 29 , wherein said test strip comprises a membrane.
31. The device of claim 29 , wherein said test strip is mounted in a groove defined in said device.
32. A device for sampling body fluid, comprising:
a body defining a capillary channel; and
a lancet disposed within said capillary channel and defining a space between said lancet and said body;
said lancet being selectively advancable and retractable;
said capillary channel being dimensioned to draw a body fluid into said space through capillary action;
said body fluid defining a meniscus when said body fluid is drawn into said space; and
said capillary channel, or said lancet, or both, being dimensioned to tend to bias said meniscus in a radially asymmetric manner when said body fluid is drawn into said space.
33. The device of claim 32 , wherein said bias tends to bias said fluid toward a testing element in spatial communication with said fluid.
34. The device of claim 33 , wherein said testing element comprises a test strip.
35. The device of claim 34 , wherein said test strip comprises a membrane.
36. The device of claim 34 , wherein said test strip is mounted in a groove defined in said device.
37. A device for sampling body fluid, comprising:
a body defining a capillary channel; and
a lancet disposed within said capillary channel and defining a space between said lancet and said body;
said lancet being selectively advancable and retractable;
said capillary channel being dimensioned to draw a body fluid into the space through capillary action;
said body fluid defining a meniscus when said body fluid is drawn into the space; and
said capillary channel, or said lancet, or both, having a relatively hydrophilic portion tending to bias said meniscus toward said hydrophilic portion when said body fluid is drawn into the space.
38. The device of claim 37 , wherein said bias tends to bias said fluid toward a testing element in spatial communication with said fluid.
39. The device of claim 38 , wherein said testing element comprises a test strip.
40. The device of claim 39 , wherein said test strip comprises a membrane.
41. The device of claim 39 , wherein said test strip is mounted in a groove defined in said device.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/732,615 US20040122339A1 (en) | 2002-12-24 | 2003-12-10 | Sampling devices and methods utilizing biased capillary action |
US12/706,015 US8083688B2 (en) | 2002-12-24 | 2010-02-16 | Sampling devices and methods utilizing biased capillary action |
US13/304,441 US20120065545A1 (en) | 2002-12-24 | 2011-11-25 | Sampling devices and methods utilizing biased capillary action |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US43633102P | 2002-12-24 | 2002-12-24 | |
US10/732,615 US20040122339A1 (en) | 2002-12-24 | 2003-12-10 | Sampling devices and methods utilizing biased capillary action |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/706,015 Continuation US8083688B2 (en) | 2002-12-24 | 2010-02-16 | Sampling devices and methods utilizing biased capillary action |
Publications (1)
Publication Number | Publication Date |
---|---|
US20040122339A1 true US20040122339A1 (en) | 2004-06-24 |
Family
ID=32713063
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/732,615 Abandoned US20040122339A1 (en) | 2002-12-24 | 2003-12-10 | Sampling devices and methods utilizing biased capillary action |
US12/706,015 Expired - Fee Related US8083688B2 (en) | 2002-12-24 | 2010-02-16 | Sampling devices and methods utilizing biased capillary action |
US13/304,441 Abandoned US20120065545A1 (en) | 2002-12-24 | 2011-11-25 | Sampling devices and methods utilizing biased capillary action |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/706,015 Expired - Fee Related US8083688B2 (en) | 2002-12-24 | 2010-02-16 | Sampling devices and methods utilizing biased capillary action |
US13/304,441 Abandoned US20120065545A1 (en) | 2002-12-24 | 2011-11-25 | Sampling devices and methods utilizing biased capillary action |
Country Status (4)
Country | Link |
---|---|
US (3) | US20040122339A1 (en) |
EP (1) | EP1578270B1 (en) |
AU (1) | AU2003297853A1 (en) |
WO (1) | WO2004060160A1 (en) |
Cited By (74)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060052723A1 (en) * | 2004-09-09 | 2006-03-09 | Roe Steven N | Device for sampling bodily fluids |
WO2006030201A1 (en) | 2004-09-13 | 2006-03-23 | Microsample Ltd. | Method and apparatus for sampling and analysis of fluids |
US20070219573A1 (en) * | 2002-04-19 | 2007-09-20 | Dominique Freeman | Method and apparatus for penetrating tissue |
US20090099478A1 (en) * | 2006-03-13 | 2009-04-16 | Microsample Ltd | Method and apparatus for piercing the skin and delivery or collection of liquids |
US7648468B2 (en) | 2002-04-19 | 2010-01-19 | Pelikon Technologies, Inc. | Method and apparatus for penetrating tissue |
US7666149B2 (en) | 1997-12-04 | 2010-02-23 | Peliken Technologies, Inc. | Cassette of lancet cartridges for sampling blood |
US7674232B2 (en) | 2002-04-19 | 2010-03-09 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US20100069793A1 (en) * | 2004-09-09 | 2010-03-18 | Roe Steven N | Device for sampling bodily fluids |
US7682318B2 (en) | 2001-06-12 | 2010-03-23 | Pelikan Technologies, Inc. | Blood sampling apparatus and method |
US7699791B2 (en) | 2001-06-12 | 2010-04-20 | Pelikan Technologies, Inc. | Method and apparatus for improving success rate of blood yield from a fingerstick |
US7708701B2 (en) | 2002-04-19 | 2010-05-04 | Pelikan Technologies, Inc. | Method and apparatus for a multi-use body fluid sampling device |
US7717863B2 (en) | 2002-04-19 | 2010-05-18 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7731729B2 (en) | 2002-04-19 | 2010-06-08 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7749174B2 (en) | 2001-06-12 | 2010-07-06 | Pelikan Technologies, Inc. | Method and apparatus for lancet launching device intergrated onto a blood-sampling cartridge |
US7780631B2 (en) | 1998-03-30 | 2010-08-24 | Pelikan Technologies, Inc. | Apparatus and method for penetration with shaft having a sensor for sensing penetration depth |
US7822454B1 (en) | 2005-01-03 | 2010-10-26 | Pelikan Technologies, Inc. | Fluid sampling device with improved analyte detecting member configuration |
US7833171B2 (en) | 2002-04-19 | 2010-11-16 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7850621B2 (en) | 2003-06-06 | 2010-12-14 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
US7850622B2 (en) | 2001-06-12 | 2010-12-14 | Pelikan Technologies, Inc. | Tissue penetration device |
US7862520B2 (en) | 2002-04-19 | 2011-01-04 | Pelikan Technologies, Inc. | Body fluid sampling module with a continuous compression tissue interface surface |
US7874994B2 (en) | 2002-04-19 | 2011-01-25 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7892185B2 (en) | 2002-04-19 | 2011-02-22 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
US7892183B2 (en) | 2002-04-19 | 2011-02-22 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
US7901362B2 (en) | 2002-04-19 | 2011-03-08 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7901365B2 (en) | 2002-04-19 | 2011-03-08 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7909777B2 (en) | 2002-04-19 | 2011-03-22 | Pelikan Technologies, Inc | Method and apparatus for penetrating tissue |
US7914465B2 (en) | 2002-04-19 | 2011-03-29 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7976476B2 (en) | 2002-04-19 | 2011-07-12 | Pelikan Technologies, Inc. | Device and method for variable speed lancet |
US7988645B2 (en) | 2001-06-12 | 2011-08-02 | Pelikan Technologies, Inc. | Self optimizing lancing device with adaptation means to temporal variations in cutaneous properties |
US8007446B2 (en) | 2002-04-19 | 2011-08-30 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8079960B2 (en) | 2002-04-19 | 2011-12-20 | Pelikan Technologies, Inc. | Methods and apparatus for lancet actuation |
US8197421B2 (en) | 2002-04-19 | 2012-06-12 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8221334B2 (en) | 2002-04-19 | 2012-07-17 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US8231832B2 (en) | 2003-03-24 | 2012-07-31 | Intuity Medical, Inc. | Analyte concentration detection devices and methods |
US8262614B2 (en) | 2003-05-30 | 2012-09-11 | Pelikan Technologies, Inc. | Method and apparatus for fluid injection |
US8267870B2 (en) | 2002-04-19 | 2012-09-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for body fluid sampling with hybrid actuation |
US8282576B2 (en) | 2003-09-29 | 2012-10-09 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for an improved sample capture device |
US8337421B2 (en) | 2001-06-12 | 2012-12-25 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US8360992B2 (en) | 2002-04-19 | 2013-01-29 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US8360993B2 (en) | 2005-09-30 | 2013-01-29 | Intuity Medical, Inc. | Method for body fluid sample extraction |
GB2495010A (en) * | 2010-06-30 | 2013-03-27 | Schlumberger Holdings | Identification of neutron capture from a pulsed neutron logging tool |
US8435190B2 (en) | 2002-04-19 | 2013-05-07 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US8556829B2 (en) | 2002-04-19 | 2013-10-15 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US8574895B2 (en) | 2002-12-30 | 2013-11-05 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus using optical techniques to measure analyte levels |
US8641644B2 (en) | 2000-11-21 | 2014-02-04 | Sanofi-Aventis Deutschland Gmbh | Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means |
US8652831B2 (en) | 2004-12-30 | 2014-02-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for analyte measurement test time |
US8668656B2 (en) | 2003-12-31 | 2014-03-11 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for improving fluidic flow and sample capture |
US8702624B2 (en) | 2006-09-29 | 2014-04-22 | Sanofi-Aventis Deutschland Gmbh | Analyte measurement device with a single shot actuator |
US8721671B2 (en) | 2001-06-12 | 2014-05-13 | Sanofi-Aventis Deutschland Gmbh | Electric lancet actuator |
US8784335B2 (en) | 2002-04-19 | 2014-07-22 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling device with a capacitive sensor |
US8801631B2 (en) * | 2005-09-30 | 2014-08-12 | Intuity Medical, Inc. | Devices and methods for facilitating fluid transport |
US8828203B2 (en) | 2004-05-20 | 2014-09-09 | Sanofi-Aventis Deutschland Gmbh | Printable hydrogels for biosensors |
US8919605B2 (en) | 2009-11-30 | 2014-12-30 | Intuity Medical, Inc. | Calibration material delivery devices and methods |
US8965476B2 (en) | 2010-04-16 | 2015-02-24 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US8969097B2 (en) | 2005-06-13 | 2015-03-03 | Intuity Medical, Inc. | Analyte detection devices and methods with hematocrit-volume correction and feedback control |
US9144401B2 (en) | 2003-06-11 | 2015-09-29 | Sanofi-Aventis Deutschland Gmbh | Low pain penetrating member |
US9226699B2 (en) | 2002-04-19 | 2016-01-05 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling module with a continuous compression tissue interface surface |
US9248267B2 (en) | 2002-04-19 | 2016-02-02 | Sanofi-Aventis Deustchland Gmbh | Tissue penetration device |
US9314194B2 (en) | 2002-04-19 | 2016-04-19 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US9351680B2 (en) | 2003-10-14 | 2016-05-31 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a variable user interface |
US9375169B2 (en) | 2009-01-30 | 2016-06-28 | Sanofi-Aventis Deutschland Gmbh | Cam drive for managing disposable penetrating member actions with a single motor and motor and control system |
US9386944B2 (en) | 2008-04-11 | 2016-07-12 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for analyte detecting device |
US9427532B2 (en) | 2001-06-12 | 2016-08-30 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US9636051B2 (en) | 2008-06-06 | 2017-05-02 | Intuity Medical, Inc. | Detection meter and mode of operation |
US9775553B2 (en) | 2004-06-03 | 2017-10-03 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a fluid sampling device |
US9782114B2 (en) | 2011-08-03 | 2017-10-10 | Intuity Medical, Inc. | Devices and methods for body fluid sampling and analysis |
US9795747B2 (en) | 2010-06-02 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Methods and apparatus for lancet actuation |
US9820684B2 (en) | 2004-06-03 | 2017-11-21 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a fluid sampling device |
US9833183B2 (en) | 2008-05-30 | 2017-12-05 | Intuity Medical, Inc. | Body fluid sampling device—sampling site interface |
US10330667B2 (en) | 2010-06-25 | 2019-06-25 | Intuity Medical, Inc. | Analyte monitoring methods and systems |
US10383556B2 (en) | 2008-06-06 | 2019-08-20 | Intuity Medical, Inc. | Medical diagnostic devices and methods |
US10729386B2 (en) | 2013-06-21 | 2020-08-04 | Intuity Medical, Inc. | Analyte monitoring system with audible feedback |
US10772550B2 (en) | 2002-02-08 | 2020-09-15 | Intuity Medical, Inc. | Autonomous, ambulatory analyte monitor or drug delivery device |
WO2022050399A1 (en) * | 2020-09-03 | 2022-03-10 | セルスペクト株式会社 | Liquid-harvesting implement, method for manufacturing liquid-harvesting implement, and inspection kit |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2384699B1 (en) * | 2010-05-06 | 2012-12-12 | Roche Diagnostics GmbH | Lancet cartridge and method for its production |
US9901922B2 (en) | 2014-07-25 | 2018-02-27 | General Electric Company | Sample collection and transfer device |
US9480981B2 (en) | 2014-07-25 | 2016-11-01 | General Electric Company | Sample collection and transfer device |
Citations (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3623475A (en) * | 1968-07-26 | 1971-11-30 | Micromedic Systems Inc | Blood collector device |
US4360016A (en) * | 1980-07-01 | 1982-11-23 | Transidyne General Corp. | Blood collecting device |
US4416279A (en) * | 1981-06-19 | 1983-11-22 | Lindner James A | Capillary blood sampling device |
US4503856A (en) * | 1981-06-29 | 1985-03-12 | Sherwood Medical Company | Lancet injector |
US4517978A (en) * | 1983-01-13 | 1985-05-21 | Levin Paul D | Blood sampling instrument |
US4637403A (en) * | 1985-04-08 | 1987-01-20 | Garid, Inc. | Glucose medical monitoring system |
US4850973A (en) * | 1987-10-16 | 1989-07-25 | Pavel Jordon & Associates | Plastic device for injection and obtaining blood samples |
US4869249A (en) * | 1987-05-01 | 1989-09-26 | Owen Mumford Limited | Blood sampling devices |
US4920977A (en) * | 1988-10-25 | 1990-05-01 | Becton, Dickinson And Company | Blood collection assembly with lancet and microcollection tube |
US4924879A (en) * | 1988-10-07 | 1990-05-15 | Brien Walter J O | Blood lancet device |
US5139489A (en) * | 1991-01-07 | 1992-08-18 | Smiths Industries Medical Systems, Inc. | Needle protection device |
US5298224A (en) * | 1988-01-14 | 1994-03-29 | Novo Nordisk A/S | Apparatus for determination of the coagulation time of a blood sample |
US5318584A (en) * | 1992-04-13 | 1994-06-07 | Boehringer Mannheim Gmbh | Blood lancet device for withdrawing blood for diagnostic purposes |
US5320607A (en) * | 1992-02-13 | 1994-06-14 | Kabushiki Kaisya Advance | Simple blood sampling device |
US5322609A (en) * | 1992-09-24 | 1994-06-21 | Becton, Dickinson And Company | Device for detecting electrolytes in liquid samples |
US5368047A (en) * | 1993-04-28 | 1994-11-29 | Nissho Corporation | Suction-type blood sampler |
US5402798A (en) * | 1991-07-18 | 1995-04-04 | Swierczek; Remi | Disposable skin perforator and blood testing device |
US5879311A (en) * | 1996-05-17 | 1999-03-09 | Mercury Diagnostics, Inc. | Body fluid sampling device and methods of use |
US6048352A (en) * | 1996-05-17 | 2000-04-11 | Mercury Diagnostics, Inc. | Disposable element for use in a body fluid sampling device |
US6051392A (en) * | 1998-06-10 | 2000-04-18 | Matsushita Electric Industrial Co., Ltd. | Method for quantitating a substrate and measurement device used therefor |
US6146361A (en) * | 1996-09-26 | 2000-11-14 | Becton Dickinson And Company | Medication delivery pen having a 31 gauge needle |
US6315738B1 (en) * | 1999-01-04 | 2001-11-13 | Terumo Kabushiki Kaisha | Assembly having lancet and means for collecting and detecting body fluid |
US6332871B1 (en) * | 1996-05-17 | 2001-12-25 | Amira Medical | Blood and interstitial fluid sampling device |
US6375627B1 (en) * | 2000-03-02 | 2002-04-23 | Agilent Technologies, Inc. | Physiological fluid extraction with rapid analysis |
US20020049390A1 (en) * | 1999-03-12 | 2002-04-25 | Integ, Inc. | Collection well for body fluid tester |
US20020103499A1 (en) * | 2001-01-22 | 2002-08-01 | Perez Edward P. | Lancet device having capillary action |
US6468287B1 (en) * | 1996-04-30 | 2002-10-22 | Medtronic, Inc. | Lancet for capillary puncture blood samples |
US20020177788A1 (en) * | 2000-03-27 | 2002-11-28 | Alastair Hodges | Method and device for sampling and analyzing interstitial fluid and whole blood samples |
US20020188223A1 (en) * | 2001-06-08 | 2002-12-12 | Edward Perez | Devices and methods for the expression of bodily fluids from an incision |
US6571651B1 (en) * | 2000-03-27 | 2003-06-03 | Lifescan, Inc. | Method of preventing short sampling of a capillary or wicking fill device |
US20030191415A1 (en) * | 2001-03-29 | 2003-10-09 | Piet Moerman | Integrated sample testing meter |
US6830551B1 (en) * | 1999-11-08 | 2004-12-14 | Arkray, Inc. | Body fluid measuring instrument and body fluid sampler thereof |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2437668A1 (en) * | 1978-09-29 | 1980-04-25 | Thomson Csf | PROTECTED OPTICAL DISC |
US4858507A (en) * | 1983-04-20 | 1989-08-22 | Esselte Pendaflex Corporation | Mat board cutter with adjustable cutter-carrying body |
EP0166574A3 (en) | 1984-06-28 | 1987-06-16 | Mitchell P. Dombrowski, M.D. | Fetal blood sampling instrument |
US4653513A (en) | 1985-08-09 | 1987-03-31 | Dombrowski Mitchell P | Blood sampler |
NL8700277A (en) * | 1987-02-05 | 1988-09-01 | Livestock Control Holding | DEVICE FOR VACUUM AND DROPPING A LIQUID. |
US5230864A (en) * | 1991-04-10 | 1993-07-27 | Eastman Kodak Company | Gravity assisted collection device |
US5318583A (en) | 1992-05-05 | 1994-06-07 | Ryder International Corporation | Lancet actuator mechanism |
JP3304342B2 (en) | 1993-12-03 | 2002-07-22 | ニプロ株式会社 | Blood suction device |
AU3070397A (en) | 1996-05-17 | 1997-12-05 | Mercury Diagnostics Inc. | Methods and apparatus for sampling body fluid |
US6027459A (en) | 1996-12-06 | 2000-02-22 | Abbott Laboratories | Method and apparatus for obtaining blood for diagnostic tests |
US6086545A (en) | 1998-04-28 | 2000-07-11 | Amira Medical | Methods and apparatus for suctioning and pumping body fluid from an incision |
CA2449569A1 (en) | 2001-06-08 | 2002-12-19 | F. Hoffmann-La Roche Ag | Devices and methods for the expression of bodily fluids from an incision |
EP1399065B1 (en) * | 2001-06-08 | 2011-10-05 | F. Hoffmann-La Roche AG | Sampling devices and methods utilizing a stepped capillary passageway |
US7682318B2 (en) | 2001-06-12 | 2010-03-23 | Pelikan Technologies, Inc. | Blood sampling apparatus and method |
JP2005501591A (en) | 2001-08-29 | 2005-01-20 | エフ ホフマン−ラ ロッシュ アクチェン ゲゼルシャフト | Exudation method and structure for use in sampling body fluid |
-
2003
- 2003-12-10 US US10/732,615 patent/US20040122339A1/en not_active Abandoned
- 2003-12-10 WO PCT/US2003/039323 patent/WO2004060160A1/en not_active Application Discontinuation
- 2003-12-10 EP EP03796923.5A patent/EP1578270B1/en not_active Expired - Lifetime
- 2003-12-10 AU AU2003297853A patent/AU2003297853A1/en not_active Abandoned
-
2010
- 2010-02-16 US US12/706,015 patent/US8083688B2/en not_active Expired - Fee Related
-
2011
- 2011-11-25 US US13/304,441 patent/US20120065545A1/en not_active Abandoned
Patent Citations (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3623475A (en) * | 1968-07-26 | 1971-11-30 | Micromedic Systems Inc | Blood collector device |
US4360016A (en) * | 1980-07-01 | 1982-11-23 | Transidyne General Corp. | Blood collecting device |
US4416279A (en) * | 1981-06-19 | 1983-11-22 | Lindner James A | Capillary blood sampling device |
US4503856A (en) * | 1981-06-29 | 1985-03-12 | Sherwood Medical Company | Lancet injector |
US4517978A (en) * | 1983-01-13 | 1985-05-21 | Levin Paul D | Blood sampling instrument |
US4637403A (en) * | 1985-04-08 | 1987-01-20 | Garid, Inc. | Glucose medical monitoring system |
US4869249A (en) * | 1987-05-01 | 1989-09-26 | Owen Mumford Limited | Blood sampling devices |
US4858607A (en) * | 1987-10-16 | 1989-08-22 | Pavel Jordan & Associates | Plastic device for injection and obtaining blood samples |
US4850973A (en) * | 1987-10-16 | 1989-07-25 | Pavel Jordon & Associates | Plastic device for injection and obtaining blood samples |
US5298224A (en) * | 1988-01-14 | 1994-03-29 | Novo Nordisk A/S | Apparatus for determination of the coagulation time of a blood sample |
US4924879A (en) * | 1988-10-07 | 1990-05-15 | Brien Walter J O | Blood lancet device |
US4920977A (en) * | 1988-10-25 | 1990-05-01 | Becton, Dickinson And Company | Blood collection assembly with lancet and microcollection tube |
US5139489A (en) * | 1991-01-07 | 1992-08-18 | Smiths Industries Medical Systems, Inc. | Needle protection device |
US5402798A (en) * | 1991-07-18 | 1995-04-04 | Swierczek; Remi | Disposable skin perforator and blood testing device |
US5320607A (en) * | 1992-02-13 | 1994-06-14 | Kabushiki Kaisya Advance | Simple blood sampling device |
US5318584A (en) * | 1992-04-13 | 1994-06-07 | Boehringer Mannheim Gmbh | Blood lancet device for withdrawing blood for diagnostic purposes |
US5322609A (en) * | 1992-09-24 | 1994-06-21 | Becton, Dickinson And Company | Device for detecting electrolytes in liquid samples |
US5368047A (en) * | 1993-04-28 | 1994-11-29 | Nissho Corporation | Suction-type blood sampler |
US6468287B1 (en) * | 1996-04-30 | 2002-10-22 | Medtronic, Inc. | Lancet for capillary puncture blood samples |
US5879311A (en) * | 1996-05-17 | 1999-03-09 | Mercury Diagnostics, Inc. | Body fluid sampling device and methods of use |
US6048352A (en) * | 1996-05-17 | 2000-04-11 | Mercury Diagnostics, Inc. | Disposable element for use in a body fluid sampling device |
US6099484A (en) * | 1996-05-17 | 2000-08-08 | Amira Medical | Methods and apparatus for sampling and analyzing body fluid |
US6332871B1 (en) * | 1996-05-17 | 2001-12-25 | Amira Medical | Blood and interstitial fluid sampling device |
US6146361A (en) * | 1996-09-26 | 2000-11-14 | Becton Dickinson And Company | Medication delivery pen having a 31 gauge needle |
US6051392A (en) * | 1998-06-10 | 2000-04-18 | Matsushita Electric Industrial Co., Ltd. | Method for quantitating a substrate and measurement device used therefor |
US6315738B1 (en) * | 1999-01-04 | 2001-11-13 | Terumo Kabushiki Kaisha | Assembly having lancet and means for collecting and detecting body fluid |
US20020049390A1 (en) * | 1999-03-12 | 2002-04-25 | Integ, Inc. | Collection well for body fluid tester |
US6830551B1 (en) * | 1999-11-08 | 2004-12-14 | Arkray, Inc. | Body fluid measuring instrument and body fluid sampler thereof |
US6375627B1 (en) * | 2000-03-02 | 2002-04-23 | Agilent Technologies, Inc. | Physiological fluid extraction with rapid analysis |
US20020177788A1 (en) * | 2000-03-27 | 2002-11-28 | Alastair Hodges | Method and device for sampling and analyzing interstitial fluid and whole blood samples |
US6571651B1 (en) * | 2000-03-27 | 2003-06-03 | Lifescan, Inc. | Method of preventing short sampling of a capillary or wicking fill device |
US6612111B1 (en) * | 2000-03-27 | 2003-09-02 | Lifescan, Inc. | Method and device for sampling and analyzing interstitial fluid and whole blood samples |
US20020103499A1 (en) * | 2001-01-22 | 2002-08-01 | Perez Edward P. | Lancet device having capillary action |
US6866675B2 (en) * | 2001-01-22 | 2005-03-15 | Roche Diagnostics Operations, Inc. | Lancet device having capillary action |
US20030191415A1 (en) * | 2001-03-29 | 2003-10-09 | Piet Moerman | Integrated sample testing meter |
US20020188223A1 (en) * | 2001-06-08 | 2002-12-12 | Edward Perez | Devices and methods for the expression of bodily fluids from an incision |
Cited By (165)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7666149B2 (en) | 1997-12-04 | 2010-02-23 | Peliken Technologies, Inc. | Cassette of lancet cartridges for sampling blood |
US7780631B2 (en) | 1998-03-30 | 2010-08-24 | Pelikan Technologies, Inc. | Apparatus and method for penetration with shaft having a sensor for sensing penetration depth |
US8439872B2 (en) | 1998-03-30 | 2013-05-14 | Sanofi-Aventis Deutschland Gmbh | Apparatus and method for penetration with shaft having a sensor for sensing penetration depth |
US8641644B2 (en) | 2000-11-21 | 2014-02-04 | Sanofi-Aventis Deutschland Gmbh | Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means |
US8622930B2 (en) | 2001-06-12 | 2014-01-07 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US9937298B2 (en) | 2001-06-12 | 2018-04-10 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US9427532B2 (en) | 2001-06-12 | 2016-08-30 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US7682318B2 (en) | 2001-06-12 | 2010-03-23 | Pelikan Technologies, Inc. | Blood sampling apparatus and method |
US7699791B2 (en) | 2001-06-12 | 2010-04-20 | Pelikan Technologies, Inc. | Method and apparatus for improving success rate of blood yield from a fingerstick |
US8845550B2 (en) | 2001-06-12 | 2014-09-30 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US8721671B2 (en) | 2001-06-12 | 2014-05-13 | Sanofi-Aventis Deutschland Gmbh | Electric lancet actuator |
US8679033B2 (en) | 2001-06-12 | 2014-03-25 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US8641643B2 (en) | 2001-06-12 | 2014-02-04 | Sanofi-Aventis Deutschland Gmbh | Sampling module device and method |
US7749174B2 (en) | 2001-06-12 | 2010-07-06 | Pelikan Technologies, Inc. | Method and apparatus for lancet launching device intergrated onto a blood-sampling cartridge |
US9694144B2 (en) | 2001-06-12 | 2017-07-04 | Sanofi-Aventis Deutschland Gmbh | Sampling module device and method |
US9802007B2 (en) | 2001-06-12 | 2017-10-31 | Sanofi-Aventis Deutschland Gmbh | Methods and apparatus for lancet actuation |
US7981055B2 (en) | 2001-06-12 | 2011-07-19 | Pelikan Technologies, Inc. | Tissue penetration device |
US7988645B2 (en) | 2001-06-12 | 2011-08-02 | Pelikan Technologies, Inc. | Self optimizing lancing device with adaptation means to temporal variations in cutaneous properties |
US7909775B2 (en) | 2001-06-12 | 2011-03-22 | Pelikan Technologies, Inc. | Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge |
US8382683B2 (en) | 2001-06-12 | 2013-02-26 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US7850622B2 (en) | 2001-06-12 | 2010-12-14 | Pelikan Technologies, Inc. | Tissue penetration device |
US8360991B2 (en) | 2001-06-12 | 2013-01-29 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US8337421B2 (en) | 2001-06-12 | 2012-12-25 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US8282577B2 (en) | 2001-06-12 | 2012-10-09 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge |
US8216154B2 (en) | 2001-06-12 | 2012-07-10 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US8211037B2 (en) | 2001-06-12 | 2012-07-03 | Pelikan Technologies, Inc. | Tissue penetration device |
US8206317B2 (en) | 2001-06-12 | 2012-06-26 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US8206319B2 (en) | 2001-06-12 | 2012-06-26 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US8123700B2 (en) | 2001-06-12 | 2012-02-28 | Pelikan Technologies, Inc. | Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge |
US8016774B2 (en) | 2001-06-12 | 2011-09-13 | Pelikan Technologies, Inc. | Tissue penetration device |
US9560993B2 (en) | 2001-11-21 | 2017-02-07 | Sanofi-Aventis Deutschland Gmbh | Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means |
US10772550B2 (en) | 2002-02-08 | 2020-09-15 | Intuity Medical, Inc. | Autonomous, ambulatory analyte monitor or drug delivery device |
US8556829B2 (en) | 2002-04-19 | 2013-10-15 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US8388551B2 (en) | 2002-04-19 | 2013-03-05 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for multi-use body fluid sampling device with sterility barrier release |
US7981056B2 (en) | 2002-04-19 | 2011-07-19 | Pelikan Technologies, Inc. | Methods and apparatus for lancet actuation |
US7938787B2 (en) | 2002-04-19 | 2011-05-10 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7914465B2 (en) | 2002-04-19 | 2011-03-29 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7988644B2 (en) | 2002-04-19 | 2011-08-02 | Pelikan Technologies, Inc. | Method and apparatus for a multi-use body fluid sampling device with sterility barrier release |
US8007446B2 (en) | 2002-04-19 | 2011-08-30 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7909777B2 (en) | 2002-04-19 | 2011-03-22 | Pelikan Technologies, Inc | Method and apparatus for penetrating tissue |
US8062231B2 (en) | 2002-04-19 | 2011-11-22 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8079960B2 (en) | 2002-04-19 | 2011-12-20 | Pelikan Technologies, Inc. | Methods and apparatus for lancet actuation |
US20070219573A1 (en) * | 2002-04-19 | 2007-09-20 | Dominique Freeman | Method and apparatus for penetrating tissue |
US7909778B2 (en) | 2002-04-19 | 2011-03-22 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8157748B2 (en) | 2002-04-19 | 2012-04-17 | Pelikan Technologies, Inc. | Methods and apparatus for lancet actuation |
US8197423B2 (en) | 2002-04-19 | 2012-06-12 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8197421B2 (en) | 2002-04-19 | 2012-06-12 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8202231B2 (en) | 2002-04-19 | 2012-06-19 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US7901365B2 (en) | 2002-04-19 | 2011-03-08 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7901362B2 (en) | 2002-04-19 | 2011-03-08 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7892183B2 (en) | 2002-04-19 | 2011-02-22 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
US7892185B2 (en) | 2002-04-19 | 2011-02-22 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
US8221334B2 (en) | 2002-04-19 | 2012-07-17 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US9089294B2 (en) | 2002-04-19 | 2015-07-28 | Sanofi-Aventis Deutschland Gmbh | Analyte measurement device with a single shot actuator |
US8235915B2 (en) | 2002-04-19 | 2012-08-07 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US9072842B2 (en) | 2002-04-19 | 2015-07-07 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US9186468B2 (en) | 2002-04-19 | 2015-11-17 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US8267870B2 (en) | 2002-04-19 | 2012-09-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for body fluid sampling with hybrid actuation |
US9226699B2 (en) | 2002-04-19 | 2016-01-05 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling module with a continuous compression tissue interface surface |
US7874994B2 (en) | 2002-04-19 | 2011-01-25 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8905945B2 (en) | 2002-04-19 | 2014-12-09 | Dominique M. Freeman | Method and apparatus for penetrating tissue |
US7875047B2 (en) | 2002-04-19 | 2011-01-25 | Pelikan Technologies, Inc. | Method and apparatus for a multi-use body fluid sampling device with sterility barrier release |
US8360992B2 (en) | 2002-04-19 | 2013-01-29 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US7862520B2 (en) | 2002-04-19 | 2011-01-04 | Pelikan Technologies, Inc. | Body fluid sampling module with a continuous compression tissue interface surface |
US8845549B2 (en) | 2002-04-19 | 2014-09-30 | Sanofi-Aventis Deutschland Gmbh | Method for penetrating tissue |
US7648468B2 (en) | 2002-04-19 | 2010-01-19 | Pelikon Technologies, Inc. | Method and apparatus for penetrating tissue |
US8366637B2 (en) | 2002-04-19 | 2013-02-05 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US8372016B2 (en) | 2002-04-19 | 2013-02-12 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for body fluid sampling and analyte sensing |
US9907502B2 (en) | 2002-04-19 | 2018-03-06 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US7708701B2 (en) | 2002-04-19 | 2010-05-04 | Pelikan Technologies, Inc. | Method and apparatus for a multi-use body fluid sampling device |
US8382682B2 (en) | 2002-04-19 | 2013-02-26 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US9089678B2 (en) | 2002-04-19 | 2015-07-28 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US8403864B2 (en) | 2002-04-19 | 2013-03-26 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US9839386B2 (en) | 2002-04-19 | 2017-12-12 | Sanofi-Aventis Deustschland Gmbh | Body fluid sampling device with capacitive sensor |
US7674232B2 (en) | 2002-04-19 | 2010-03-09 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8414503B2 (en) | 2002-04-19 | 2013-04-09 | Sanofi-Aventis Deutschland Gmbh | Methods and apparatus for lancet actuation |
US9795334B2 (en) | 2002-04-19 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US8430828B2 (en) | 2002-04-19 | 2013-04-30 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a multi-use body fluid sampling device with sterility barrier release |
US8435190B2 (en) | 2002-04-19 | 2013-05-07 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US7833171B2 (en) | 2002-04-19 | 2010-11-16 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8491500B2 (en) | 2002-04-19 | 2013-07-23 | Sanofi-Aventis Deutschland Gmbh | Methods and apparatus for lancet actuation |
US8496601B2 (en) | 2002-04-19 | 2013-07-30 | Sanofi-Aventis Deutschland Gmbh | Methods and apparatus for lancet actuation |
US9724021B2 (en) | 2002-04-19 | 2017-08-08 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US8562545B2 (en) | 2002-04-19 | 2013-10-22 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US7976476B2 (en) | 2002-04-19 | 2011-07-12 | Pelikan Technologies, Inc. | Device and method for variable speed lancet |
US8579831B2 (en) | 2002-04-19 | 2013-11-12 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US8808201B2 (en) | 2002-04-19 | 2014-08-19 | Sanofi-Aventis Deutschland Gmbh | Methods and apparatus for penetrating tissue |
US8636673B2 (en) | 2002-04-19 | 2014-01-28 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US9498160B2 (en) | 2002-04-19 | 2016-11-22 | Sanofi-Aventis Deutschland Gmbh | Method for penetrating tissue |
US7731729B2 (en) | 2002-04-19 | 2010-06-08 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US9248267B2 (en) | 2002-04-19 | 2016-02-02 | Sanofi-Aventis Deustchland Gmbh | Tissue penetration device |
US9314194B2 (en) | 2002-04-19 | 2016-04-19 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US7717863B2 (en) | 2002-04-19 | 2010-05-18 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8690796B2 (en) | 2002-04-19 | 2014-04-08 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US9339612B2 (en) | 2002-04-19 | 2016-05-17 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US7713214B2 (en) | 2002-04-19 | 2010-05-11 | Pelikan Technologies, Inc. | Method and apparatus for a multi-use body fluid sampling device with optical analyte sensing |
US8784335B2 (en) | 2002-04-19 | 2014-07-22 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling device with a capacitive sensor |
US9034639B2 (en) | 2002-12-30 | 2015-05-19 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus using optical techniques to measure analyte levels |
US8574895B2 (en) | 2002-12-30 | 2013-11-05 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus using optical techniques to measure analyte levels |
US8231832B2 (en) | 2003-03-24 | 2012-07-31 | Intuity Medical, Inc. | Analyte concentration detection devices and methods |
US9095292B2 (en) | 2003-03-24 | 2015-08-04 | Intuity Medical, Inc. | Analyte concentration detection devices and methods |
US8262614B2 (en) | 2003-05-30 | 2012-09-11 | Pelikan Technologies, Inc. | Method and apparatus for fluid injection |
US7850621B2 (en) | 2003-06-06 | 2010-12-14 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
US8251921B2 (en) | 2003-06-06 | 2012-08-28 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for body fluid sampling and analyte sensing |
US10034628B2 (en) | 2003-06-11 | 2018-07-31 | Sanofi-Aventis Deutschland Gmbh | Low pain penetrating member |
US9144401B2 (en) | 2003-06-11 | 2015-09-29 | Sanofi-Aventis Deutschland Gmbh | Low pain penetrating member |
US8282576B2 (en) | 2003-09-29 | 2012-10-09 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for an improved sample capture device |
US8945910B2 (en) | 2003-09-29 | 2015-02-03 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for an improved sample capture device |
US9351680B2 (en) | 2003-10-14 | 2016-05-31 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a variable user interface |
US8296918B2 (en) | 2003-12-31 | 2012-10-30 | Sanofi-Aventis Deutschland Gmbh | Method of manufacturing a fluid sampling device with improved analyte detecting member configuration |
US8668656B2 (en) | 2003-12-31 | 2014-03-11 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for improving fluidic flow and sample capture |
US9561000B2 (en) | 2003-12-31 | 2017-02-07 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for improving fluidic flow and sample capture |
US8828203B2 (en) | 2004-05-20 | 2014-09-09 | Sanofi-Aventis Deutschland Gmbh | Printable hydrogels for biosensors |
US9261476B2 (en) | 2004-05-20 | 2016-02-16 | Sanofi Sa | Printable hydrogel for biosensors |
US9775553B2 (en) | 2004-06-03 | 2017-10-03 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a fluid sampling device |
US9820684B2 (en) | 2004-06-03 | 2017-11-21 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a fluid sampling device |
US20060052723A1 (en) * | 2004-09-09 | 2006-03-09 | Roe Steven N | Device for sampling bodily fluids |
US8419657B2 (en) | 2004-09-09 | 2013-04-16 | Roche Diagnostics Operations, Inc. | Device for sampling bodily fluids |
US7604604B2 (en) | 2004-09-09 | 2009-10-20 | Roche Diagnostics Operations, Inc. | Device for sampling bodily fluids |
US20100069793A1 (en) * | 2004-09-09 | 2010-03-18 | Roe Steven N | Device for sampling bodily fluids |
US8092394B2 (en) * | 2004-09-13 | 2012-01-10 | Microsample Ltd. | Method and apparatus for sampling and analysis of fluids |
US20070232956A1 (en) * | 2004-09-13 | 2007-10-04 | Microsample Ltd. | Method and Apparatus for Sampling and Analysis of Fluids |
WO2006030201A1 (en) | 2004-09-13 | 2006-03-23 | Microsample Ltd. | Method and apparatus for sampling and analysis of fluids |
US8652831B2 (en) | 2004-12-30 | 2014-02-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for analyte measurement test time |
US7822454B1 (en) | 2005-01-03 | 2010-10-26 | Pelikan Technologies, Inc. | Fluid sampling device with improved analyte detecting member configuration |
US10226208B2 (en) | 2005-06-13 | 2019-03-12 | Intuity Medical, Inc. | Analyte detection devices and methods with hematocrit/volume correction and feedback control |
US11419532B2 (en) | 2005-06-13 | 2022-08-23 | Intuity Medical, Inc. | Analyte detection devices and methods with hematocrit/volume correction and feedback control |
US8969097B2 (en) | 2005-06-13 | 2015-03-03 | Intuity Medical, Inc. | Analyte detection devices and methods with hematocrit-volume correction and feedback control |
US9366636B2 (en) | 2005-06-13 | 2016-06-14 | Intuity Medical, Inc. | Analyte detection devices and methods with hematocrit/volume correction and feedback control |
US10441205B2 (en) | 2005-09-30 | 2019-10-15 | Intuity Medical, Inc. | Multi-site body fluid sampling and analysis cartridge |
US10842427B2 (en) | 2005-09-30 | 2020-11-24 | Intuity Medical, Inc. | Body fluid sampling arrangements |
US9060723B2 (en) | 2005-09-30 | 2015-06-23 | Intuity Medical, Inc. | Body fluid sampling arrangements |
US9380974B2 (en) | 2005-09-30 | 2016-07-05 | Intuity Medical, Inc. | Multi-site body fluid sampling and analysis cartridge |
US10433780B2 (en) | 2005-09-30 | 2019-10-08 | Intuity Medical, Inc. | Devices and methods for facilitating fluid transport |
US8801631B2 (en) * | 2005-09-30 | 2014-08-12 | Intuity Medical, Inc. | Devices and methods for facilitating fluid transport |
US8360993B2 (en) | 2005-09-30 | 2013-01-29 | Intuity Medical, Inc. | Method for body fluid sample extraction |
US8360994B2 (en) | 2005-09-30 | 2013-01-29 | Intuity Medical, Inc. | Arrangement for body fluid sample extraction |
US8795201B2 (en) | 2005-09-30 | 2014-08-05 | Intuity Medical, Inc. | Catalysts for body fluid sample extraction |
US8382681B2 (en) | 2005-09-30 | 2013-02-26 | Intuity Medical, Inc. | Fully integrated wearable or handheld monitor |
US9839384B2 (en) | 2005-09-30 | 2017-12-12 | Intuity Medical, Inc. | Body fluid sampling arrangements |
US20090099478A1 (en) * | 2006-03-13 | 2009-04-16 | Microsample Ltd | Method and apparatus for piercing the skin and delivery or collection of liquids |
US8702624B2 (en) | 2006-09-29 | 2014-04-22 | Sanofi-Aventis Deutschland Gmbh | Analyte measurement device with a single shot actuator |
US9386944B2 (en) | 2008-04-11 | 2016-07-12 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for analyte detecting device |
US11045125B2 (en) | 2008-05-30 | 2021-06-29 | Intuity Medical, Inc. | Body fluid sampling device-sampling site interface |
US9833183B2 (en) | 2008-05-30 | 2017-12-05 | Intuity Medical, Inc. | Body fluid sampling device—sampling site interface |
US11399744B2 (en) | 2008-06-06 | 2022-08-02 | Intuity Medical, Inc. | Detection meter and mode of operation |
US10383556B2 (en) | 2008-06-06 | 2019-08-20 | Intuity Medical, Inc. | Medical diagnostic devices and methods |
US9636051B2 (en) | 2008-06-06 | 2017-05-02 | Intuity Medical, Inc. | Detection meter and mode of operation |
US11553860B2 (en) | 2008-06-06 | 2023-01-17 | Intuity Medical, Inc. | Medical diagnostic devices and methods |
US9375169B2 (en) | 2009-01-30 | 2016-06-28 | Sanofi-Aventis Deutschland Gmbh | Cam drive for managing disposable penetrating member actions with a single motor and motor and control system |
US11002743B2 (en) | 2009-11-30 | 2021-05-11 | Intuity Medical, Inc. | Calibration material delivery devices and methods |
US8919605B2 (en) | 2009-11-30 | 2014-12-30 | Intuity Medical, Inc. | Calibration material delivery devices and methods |
US11933789B2 (en) | 2009-11-30 | 2024-03-19 | Intuity Medical, Inc. | Calibration material delivery devices and methods |
US9897610B2 (en) | 2009-11-30 | 2018-02-20 | Intuity Medical, Inc. | Calibration material delivery devices and methods |
US8965476B2 (en) | 2010-04-16 | 2015-02-24 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US9795747B2 (en) | 2010-06-02 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Methods and apparatus for lancet actuation |
US10330667B2 (en) | 2010-06-25 | 2019-06-25 | Intuity Medical, Inc. | Analyte monitoring methods and systems |
GB2495010A (en) * | 2010-06-30 | 2013-03-27 | Schlumberger Holdings | Identification of neutron capture from a pulsed neutron logging tool |
GB2495010B (en) * | 2010-06-30 | 2016-02-17 | Schlumberger Holdings | Identification of neutron capture from a pulsed neutron logging tool |
US9782114B2 (en) | 2011-08-03 | 2017-10-10 | Intuity Medical, Inc. | Devices and methods for body fluid sampling and analysis |
US11672452B2 (en) | 2011-08-03 | 2023-06-13 | Intuity Medical, Inc. | Devices and methods for body fluid sampling and analysis |
US11051734B2 (en) | 2011-08-03 | 2021-07-06 | Intuity Medical, Inc. | Devices and methods for body fluid sampling and analysis |
US11382544B2 (en) | 2011-08-03 | 2022-07-12 | Intuity Medical, Inc. | Devices and methods for body fluid sampling and analysis |
US10729386B2 (en) | 2013-06-21 | 2020-08-04 | Intuity Medical, Inc. | Analyte monitoring system with audible feedback |
WO2022050399A1 (en) * | 2020-09-03 | 2022-03-10 | セルスペクト株式会社 | Liquid-harvesting implement, method for manufacturing liquid-harvesting implement, and inspection kit |
Also Published As
Publication number | Publication date |
---|---|
US8083688B2 (en) | 2011-12-27 |
EP1578270A1 (en) | 2005-09-28 |
AU2003297853A1 (en) | 2004-07-29 |
US20100145228A1 (en) | 2010-06-10 |
US20120065545A1 (en) | 2012-03-15 |
EP1578270B1 (en) | 2018-08-01 |
WO2004060160A1 (en) | 2004-07-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8083688B2 (en) | Sampling devices and methods utilizing biased capillary action | |
US7476202B2 (en) | Sampling devices and methods utilizing a horizontal capillary test strip | |
US7244264B2 (en) | Dual blade lancing test strip | |
US20060052723A1 (en) | Device for sampling bodily fluids | |
US7264627B2 (en) | Wicking methods and structures for use in sampling bodily fluids | |
US9554741B2 (en) | Precision depth control lancing tip | |
US6501976B1 (en) | Percutaneous biological fluid sampling and analyte measurement devices and methods | |
AU784699B2 (en) | Percutaneous biological fluid sampling and analyte measurement devices and methods | |
JP4365116B2 (en) | Puncture needle integrated minimal invasive optical format | |
US7247144B2 (en) | Methods and apparatus for sampling and analyzing body fluid | |
JP2004249078A (en) | Sensor with integrated lance | |
WO2004107970A1 (en) | Integrated test element for a one-time drawing and analyzing of a sample to be analyzed | |
CA2449738C (en) | Sampling devices and methods utilizing a stepped capillary passageway | |
WO2002100275A1 (en) | Sampling devices and methods for bodily fluids | |
Zhang et al. | MEMS-based microsystem for minimally invasive optical monitoring of blood glucose |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: ROCHE DIAGNOSTICS OPERATIONS, INC., INDIANA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ROE, STEVEN N.;REEL/FRAME:014715/0468 Effective date: 20040525 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |
|
AS | Assignment |
Owner name: ROCHE DIABETES CARE, INC., INDIANA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ROCHE DIAGNOSTICS OPERATIONS, INC.;REEL/FRAME:036008/0670 Effective date: 20150302 |